Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease
Kinya Okamoto, Masahiko Koda, Toshiaki Okamoto, Takumi Onoyama, Kenichi Miyoshi, Manabu Kishina, Tomomitsu Matono, Jun Kato, Shiho Tokunaga, Takaaki Sugihara, Akira Hiramatsu, Hideyuki Hyogo, Hiroshi Tobita, Shuichi Sato, Miwa Kawanaka, , Hajime Isomoto
This study investigates miR-379 as a biomarker for NAFLD, finding it upregulated in patients and correlated with cholesterol levels.
PLoS ONE · Feb 27, 2020Peer-reviewedMolecular Biology